Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical composition containing hirudin and hementerin and application thereof

A technology of hirudin and drugs, which is applied in the direction of drug combinations, medical preparations containing active ingredients, and pharmaceutical formulas, and can solve problems such as insufficient preventive measures and difficulty in obtaining effective and fair medical services

Active Publication Date: 2011-06-08
CHONGQING DUOPUTAI PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In these countries, people with cardiovascular and other noncommunicable diseases have limited access to effective and equitable health services (including early detection services) that meet their needs, and preventive measures are insufficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical composition containing hirudin and hementerin and application thereof
  • Medical composition containing hirudin and hementerin and application thereof
  • Medical composition containing hirudin and hementerin and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] The raw materials of the pharmaceutical composition are 0.1 g of hirudin, 1 g of hyaluronidase and 0.1 g of fibrinolysin. The application of the drug whose raw materials are hirudin, hyaluronidase and fibrinolysin in the preparation of the drug for treating cardiovascular disease.

[0067] The medicine is enteric-coated tablet, enteric-coated capsule or enteric-coated pellet.

Embodiment 2

[0069] The raw materials of the pharmaceutical composition are 1 g of hirudin, 5 g of hyaluronidase and 0.1 g of fibrinolysin. The application of the drug whose raw materials are hirudin, hyaluronidase and fibrinolysin in the preparation of the drug for treating cardiovascular disease.

[0070] The medicine is enteric-coated tablet, enteric-coated capsule or enteric-coated pellet.

Embodiment 3

[0072] The raw materials of the pharmaceutical composition are 0.1 g of hirudin, 5 g of hyaluronidase and 0.2 g of fibrinolysin. The application of the drug whose raw materials are hirudin, hyaluronidase and fibrinolysin in the preparation of the drug for treating cardiovascular disease.

[0073] The medicine is enteric-coated tablet, enteric-coated capsule or enteric-coated pellet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicine, and discloses a medical composition containing hirudin, hyaluronidase and hementerin and application thereof in the preparation of medicaments for treating cardiovascular diseases. The test of the anti-hypoxia ability of mice, the test of the protective action on myocardial ischemia reperfusion injury of anesthetized rats and other tests prove that the medicament prepared from hirudin, hementerin and hyaluronidase has favorable pharmacological action on cardiovascular diseases, especially cardiovascular diseases caused by coronary heart diseases, angina pectoris and endothelial cell injury.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a pharmaceutical composition whose raw materials are hirudin, hyaluronidase and fibrinolysin and a new application of the pharmaceutical composition. Background technique [0002] Cardiovascular disease, also known as circulatory system disease, is a series of diseases involving the circulatory system. The circulatory system refers to the organs and tissues that transport blood in the human body, mainly including the heart, blood vessels (arteries, veins, capillaries), and can be subdivided into acute And chronic, generally related to arteriosclerosis. These diseases all have similar etiology, pathogenesis and treatment methods. At present, the most cardiovascular diseases are coronary heart disease and angina pectoris, and the symptoms are chest tightness and chest pain. [0003] Cardiovascular and cerebrovascular diseases are the leading cause...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/58A61P9/10A61K38/47A61K38/46
Inventor 甘奇志张海燕
Owner CHONGQING DUOPUTAI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com